BASP1 is a transcriptional cosuppressor for the Wilms' tumor suppressor protein WT1

被引:110
作者
Carpenter, B
Hill, KJ
Charalambous, M
Wagner, KJ
Lahiri, D
James, DI
Andersen, JS
Schumacher, V
Royer-Pokora, B
Mann, M
Ward, A
Roberts, SGE
机构
[1] Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England
[2] Univ Bath, Dev Biol Program, Bath BA2 7AY, Avon, England
[3] Univ Bath, Ctr Regenerat Med, Dept Biol & Biochem, Bath BA2 7AY, Avon, England
[4] Univ So Denmark, Prot Interact Lab, DK-5230 Odense, Denmark
[5] Univ Dusseldorf, Inst Human Genet & Anthropol, D-40001 Dusseldorf, Germany
基金
英国惠康基金;
关键词
D O I
10.1128/MCB.24.2.537-549.2004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Wilms' tumor suppressor protein WT1 is a transcriptional regulator that plays a key role in the development of the kidneys. The transcriptional activation domain of WT1 is subject to regulation by a suppression region within the N terminus of WT1. Using a functional assay, we provide direct evidence that this requires a transcriptional cosuppressor, which we identify as brain acid soluble protein 1 (BASP1.). WT1 and BASP1 associate within the nuclei of cells that naturally express both proteins. BASP1 can confer WT1 cosuppressor activity in transfection assays, and elimination of endogenous BASP1. expression augments transcriptional activation by WT1. BASP1 is present in the developing nephron structures of the embryonic kidney and, coincident with that of WT1, its expression is restricted to the highly specialized podocyte cells of the adult kidney. Taken together, our results show that BASP1 is a WT1-associated factor that can regulate WT1 transcriptional activity.
引用
收藏
页码:537 / 549
页数:13
相关论文
共 42 条
[1]  
ARMSTRONG JF, 1992, MECH DEVELOP, V40, P85
[2]  
AUSUBEL FM, 2002, SHORT PROTOCOLS MOL, V1, P16
[3]   A system for stable expression of short interfering RNAs in mammalian cells [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
SCIENCE, 2002, 296 (5567) :550-553
[4]  
Davies R, 1999, CANCER RES, V59, p1747S
[5]   REPRESSION OF THE INSULIN-LIKE GROWTH FACTOR-II GENE BY THE WILMS-TUMOR SUPPRESSOR WT1 [J].
DRUMMOND, IA ;
MADDEN, SL ;
ROHWERNUTTER, P ;
BELL, GI ;
SUKHATME, VP ;
RAUSCHER, FJ .
SCIENCE, 1992, 257 (5070) :674-678
[6]   WT1 SUPPRESSES SYNTHESIS OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR AND INDUCES APOPTOSIS [J].
ENGLERT, C ;
HOU, X ;
MAHESWARAN, S ;
BENNETT, P ;
NGWU, C ;
RE, GG ;
GARVIN, AJ ;
ROSNER, MR ;
HABER, DA .
EMBO JOURNAL, 1995, 14 (19) :4662-4675
[7]   WT1 - more than a transcription factor? [J].
Englert, C .
TRENDS IN BIOCHEMICAL SCIENCES, 1998, 23 (10) :389-393
[8]   WT1 is a key regulator of podocyte function: reduced expression levels cause crescentic glomerulonephritis and mesangial sclerosis [J].
Guo, JK ;
Menke, AL ;
Gubler, MC ;
Clarke, AR ;
Harrison, D ;
Hammes, A ;
Hastie, ND ;
Schedl, A .
HUMAN MOLECULAR GENETICS, 2002, 11 (06) :651-659
[9]   Two splice variants of the Wilms' tumor 1 gene have distinct functions during sex determination and nephron formation [J].
Hammes, A ;
Guo, JK ;
Lutsch, G ;
Leheste, JR ;
Landrock, D ;
Ziegler, U ;
Gubler, MC ;
Schedl, A .
CELL, 2001, 106 (03) :319-329
[10]   Life, sex, and WT1 isoforms - Three amino acids can make all the difference [J].
Hastie, ND .
CELL, 2001, 106 (04) :391-394